Orgenesis, Inc. (ORGS)
0.4124
+0.38
(+1161.16%)
USD |
OTCM |
Sep 08, 16:00
Orgenesis 1 Year Total Returns (Daily) : 157.8% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 157.8% |
| September 04, 2026 | -95.78% |
| September 03, 2026 | -78.20% |
| September 02, 2026 | -56.25% |
| September 01, 2026 | -65.00% |
| August 31, 2026 | -65.00% |
| August 28, 2026 | -89.00% |
| August 27, 2026 | -96.73% |
| August 26, 2026 | 48.64% |
| August 25, 2026 | 480.0% |
| August 24, 2026 | 490.0% |
| August 21, 2026 | -90.00% |
| August 20, 2026 | -28.49% |
| August 19, 2026 | 2.19% |
| August 18, 2026 | 113.5% |
| August 17, 2026 | 1.49K% |
| August 14, 2026 | 1.49K% |
| August 13, 2026 | 1.49K% |
| August 12, 2026 | 1.49K% |
| August 11, 2026 | -56.25% |
| August 10, 2026 | -60.67% |
| August 07, 2026 | 473.8% |
| August 06, 2026 | 1.49K% |
| August 05, 2026 | 1.81K% |
| August 04, 2026 | 260.4% |
| Date | Value |
|---|---|
| August 03, 2026 | -70.00% |
| July 31, 2026 | 3.13K% |
| July 30, 2026 | -55.56% |
| July 29, 2026 | 399.9K% |
| July 28, 2026 | -60.00% |
| July 27, 2026 | -60.00% |
| July 24, 2026 | -60.00% |
| July 23, 2026 | -60.00% |
| July 22, 2026 | -60.40% |
| July 21, 2026 | -60.40% |
| July 20, 2026 | -61.54% |
| July 17, 2026 | -99.62% |
| July 16, 2026 | -99.91% |
| July 15, 2026 | -98.40% |
| July 14, 2026 | -98.31% |
| July 13, 2026 | -99.91% |
| July 10, 2026 | -71.38% |
| July 09, 2026 | -87.92% |
| July 08, 2026 | -71.65% |
| July 07, 2026 | -73.51% |
| July 06, 2026 | -69.92% |
| July 02, 2026 | -73.86% |
| July 01, 2026 | -73.86% |
| June 30, 2026 | -72.88% |
| June 29, 2026 | -73.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agenus, Inc. | 74.41% |
| Amgen, Inc. | 44.20% |
| Anika Therapeutics, Inc. | 135.3% |
| BioCryst Pharmaceuticals, Inc. | 10.68% |
| Imunon, Inc. | -73.54% |